Angiotensin-converting-enzyme gene insertion-deletion polymorphism and renin angiotensin aldosterone system activity in different phenotypes of polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is a common condition. Its pathophysiology involves an interaction between genetic and environmental factors, resulting in different reproductive and metabolic subtypes. Genetic variation in the angiotensin converting enzyme (ACE) gene has been implicated in the path...

Full description

Bibliographic Details
Published in:	Heliyon
Main Authors:	Khansa Chaabouni, Amana Saadallah-Kallel, Samia Ben Brahim, Kais Chaabane, Madiha Frikha, Mouna Mnif, Leila Keskes, Fatma Abdelhedi, Fatma Ayadi
Format:	Article
Language:	English
Published:	Elsevier 2024-11-01
Subjects:	Renin-angiotensin-aldosterone system ACE gene polymorphism Plasma ACE activity PCOS phenotypes Pathophysiology Renin
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024164420

Similar Items

Is the prognosis of non‐hypertensive, COVID‐19 patients treated with renin–angiotensin–aldosterone system inhibitors more uncertain?
by: Juan José García Martínez, et al.
Published: (2022-11-01)

Lock, Stock and Barrel: Role of Renin-Angiotensin-Aldosterone System in Coronavirus Disease 2019
by: Christian Zanza, et al.
Published: (2021-07-01)

The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation
by: Agnese Valentini, et al.
Published: (2025-08-01)

Effects of Interactions among Gene Polymorphisms of the Renin–Angiotensin-Aldosterone System on Hypertension in Turkish People from Southeast Anatolia
by: Arpacı Abdullah, et al.
Published: (2019-04-01)

The evolutionary development of the renin angiotensin aldosterone system and its importance for the survival of the human species
by: Natalia Butt-Hussaim, et al.
Published: (2021-03-01)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)

The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies
by: Bahareh Hassani, et al.
Published: (2023-10-01)

Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01)

Clinical perspectives and fundamental aspects of local cardiovascular and renal renin-angiotensin systems
by: Walmor eDe Mello, et al.
Published: (2014-02-01)

Advances in Unraveling the Role of the Renin-Angiotensin-AldosteroneSystem in Osteoporosis Pathogenesis
by: Zige Liu, et al.
Published: (2024-01-01)

Activation of the renin-angiotensin-aldosterone system in mares around ovulation
by: Katy Satué, et al.
Published: (2017-06-01)

Regulation of the renin-angiotensin-aldosterone system by cyclic nucleotides and phosphodiesterases
by: Stepan Gambaryan, et al.
Published: (2023-08-01)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01)

Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin–angiotensin–aldosterone system on COVID-19 disease
by: Christian M. Zobel, et al.
Published: (2024-01-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)

The renin-angiotensin system and its blockers
by: Igić Rajko, et al.
Published: (2014-01-01)

A systematic review of nonsynonymous single nucleotide polymorphisms in the renin–angiotensin–aldosterone system
by: Tomasz Rechciński, et al.
Published: (2022-12-01)

Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study
by: Jinbo Hu, et al.
Published: (2021-12-01)

Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia
by: Daniela-Carmen Ababei, et al.
Published: (2023-09-01)

Duration of rheumatoid arthritis changes blood levels of angiotensin and aldosterone
by: Boris A. Rebrov, et al.
Published: (2023-12-01)

Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype
by: E.P. Velloso, et al.

Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype
by: E.P. Velloso, et al.
Published: (2007-04-01)

Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney disease
by: Kentaro Watanabe, et al.
Published: (2023-12-01)

Effect of Age on Aldosterone–Renin Ratio in Screening Primary Aldosteronism
by: Ning Peng, et al.
Published: (2025-03-01)

Updates on the Renin–Angiotensin–Aldosterone System and the Cardiovascular Continuum
by: Dana Pop, et al.
Published: (2024-07-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)

The state of renin-aldosterone system in patients with resistant arterial hypertension
by: О. H. Оbertynska
Published: (2019-06-01)

Biological sex differences in renin angiotensin system enzymes ACE and ACE2 regulate normal tissue response to radiation injury
by: Guru Prasad Sharma, et al.
Published: (2023-05-01)

THE RENIN-ANGIOTENSIN SYSTEM AND ITS INVOLVEMENT IN PAIN CONTROL. A NEW INSIGHT INTO AN OLD SYSTEM
by: Daniela Pechlivanova, et al.
Published: (2025-04-01)

Revisiting the renin-angiotensin-aldosterone system in the eye: Mechanistic insights and pharmacological targets
by: Francesco Buonfiglio, et al.
Published: (2025-06-01)

An Overview of the Potential Use of Ethno-Medicinal Plants Targeting the Renin–Angiotensin System in the Treatment of Hypertension
by: Pietro De Lange-Jacobs, et al.
Published: (2020-04-01)

The renin-angiotensin system in healthy human platelets: expressed but inactive
by: François Panosetti, et al.
Published: (2025-12-01)

Renal denervation inhibits the renin–angiotensin–aldosterone system in spontaneously hypertensive rats
by: Fei Qin, et al.
Published: (2022-01-01)

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model
by: Seung-Hwa Lee, et al.
Published: (2022-01-01)

Association between renin‐angiotensin antagonism and COVID‐19–related mortality in patients with essential hypertension: A single center, retrospective cohort study
by: Vijayvardhan Kamalumpundi, et al.
Published: (2024-09-01)

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
by: Marisa K. Ames, et al.
Published: (2022-11-01)